Insights

Posts Are Coming Soon
Stay tuned...

​Topic 1: Translational Medicine

Moderators

 

DENG Shaoping, President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital
SHI Yuankai, Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials

ZHANG Xiangcheng

Industry Fellow, Royal Society, United Kingdom

Topic: Innovation in Science and Collaboration: the Past, Present, and Future

YANG Zhenglin

Vice President, Sichuan Academy of Medical Science & Sichuan Provincial People’s Hospital

Topic: Research and Application of Age-related Macular Degeneration in China

YANG Shengyong

Professor, Sichuan University

Topic: Artificial Intelligence and Innovative Medicine Development

Lilach O. Lerman

Professor of Medicine and Physiology in the Mayo Medical School; Director of the Renovascular Research Laboratory, and Head of the Nephrology Research Unit at the Division of Nephrology & Hypertension at Mayo Clinic

Topic: The Obesity Epidemic: Weight and Beyond

​Topic 2: Precision Medicine

Moderators

 

RAO Keqin, Vice President and Chairman, Chinese Medical Association; President, Chinese Health Economics Association
WU Qi, Human Resources and Social Security Department of Sichuan

WEI Yuquan

Director of State Key Laboratory of Biotherapy and Cancer

Center, West China Hospital, Sichuan University; Academician, Chinese Academy of Sciences

Topic: Tumor Micro-environment and Development of Biology Medicine

XU Mei

President, International Richland Hospital, Kunming, Yunnan

Topic: Searching for Cause for Diseases

SHI Yuankai

Vice President, Chinese Academy of Medical Science Cancer Hospital, National Lab for Cancer Clinical Trials

Topic: Current Status and Prospects of Clinical Research on New Cancer Drugs in China

James Meng

President, Mevion Medical Systems, Boston, U.S.

Topic: Precision Cancer Treatment with Miniaturized Proton

Anita Katharina Wagner

Clinical Pharmacist, Pharmacoepidemiologist, and

Health Policy Researcher, Department of Population Medicine of Harvard Medical School & Harvard Pilgrim Health Care Institute

Topic: New Cancer Therapeutics in Health Systems – Opportunities and Challenges

Panel Discussion

Moderator: 


MA Jing, Director, China Center, Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care InstituteHE Xin, Managing Partner, Hyfinity Investments

Above Speakers

 

SHI Anli, President, Cancer Rehabilitation Society of China Anti-Cancer Association